Patents by Inventor Stanislaw Kantor

Stanislaw Kantor has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9053352
    Abstract: A rapid and efficient method and apparatus for detecting electrophysiologic, proarrhythmic, contractile, and other effects of substances such as compounds and drugs in native cellular cardiac preparations, the preparations representing an integrated cell-based pharmacologic response is disclosed. More specifically, a method to (1) rapidly and efficiently detect and verify the effects of chemicals, compounds and drugs on cardiac repolarization, contractility, and excitability using optically based techniques and customized simulation protocols, and (2) rapidly and efficiently screen and select compounds for electrophysiologic and proarrhythmic effects on cardiac myocytes is disclosed.
    Type: Grant
    Filed: November 11, 2011
    Date of Patent: June 9, 2015
    Assignee: AbbVie Inc.
    Inventors: Jonathan D. Trumbull, Gary A. Gintant, Stanislaw Kantor, Jeffrey Yen Pan, Gilbert J. Diaz, Jonathon Green, Zhi Su, Jeffrey A. Olson
  • Patent number: 8326388
    Abstract: A method and apparatus for non-invasive measurement of living body information comprises a light source configured to generate light containing a specific wavelength component, an irradiation unit configured to irradiate a subject with the light, and at least one acoustic signal detection unit including piezoelectric devices formed of a piezoelectric single crystal containing lead titanate and configured to detect an acoustic signal which is generated due to the energy of the irradiation light absorbed by a specific substance present in or on a subject.
    Type: Grant
    Filed: October 28, 2003
    Date of Patent: December 4, 2012
    Assignee: Toshiba Medical Systems Corporation
    Inventors: Shoichi Kanayama, Kazuhiro Itsumi, Omar S. Khalil, Stanislaw Kantor
  • Publication number: 20120134570
    Abstract: A rapid and efficient method and apparatus for detecting electrophysiologic, proarrhythmic, contractile, and other effects of substances such as compounds and drugs in native cellular cardiac preparations, the preparations representing an integrated cell-based pharmacologic response is disclosed. More specifically, a method to (1) rapidly and efficiently detect and verify the effects of chemicals, compounds and drugs on cardiac repolarization, contractility, and excitability using optically based techniques and customized simulation protocols, and (2) rapidly and efficiently screen and select compounds for electrophysiologic and proarrhythmic effects on cardiac myocytes is disclosed.
    Type: Application
    Filed: November 11, 2011
    Publication date: May 31, 2012
    Applicant: ABBOTT LABORATORIES
    Inventors: Jonathan D. Trumbull, Gary A. Gintant, Stanislaw Kantor, Jeffrey Yen Pan, Gilbert J. Diaz, Jonathon Green, Zhi Su, Jeffrey A. Olson
  • Patent number: 7167734
    Abstract: A method for collecting optical data at two morphologically similar, substantially non-overlapping, and preferably adjacent, areas on the surface of a tissue, while the temperature in each area is being maintained or modulated according to a temperature program. The optical data obtained are inserted into a mathematical relationship, e.g., an algorithm, that can be used to predict a disease state (such as the diabetes mellitus disease state) or the concentration of an analyte for indicating a physical condition (such as blood glucose level). This invention can be used to differentiate between disease status, such as, for example, diabetic and non-diabetic. The method involves the generation of a calibration (or training) set that utilizes the relationship between optical signals emanating from the skin under different thermal stimuli and disease status, e.g., diabetic status, established clinically. This calibration set can be used to predict the disease state of other subjects.
    Type: Grant
    Filed: April 13, 2001
    Date of Patent: January 23, 2007
    Assignee: Abbott Laboratories
    Inventors: Omar S. Khalil, Shu-jen Yeh, Stanislaw Kantor, Charles F. Hanna, Eric B. Shain
  • Publication number: 20070015978
    Abstract: A method and apparatus for non-invasive measurement of living body information comprises a light source configured to generate light containing a specific wavelength component, an irradiation unit configured to irradiate a subject with the light, and at least one acoustic signal detection unit including piezoelectric devices formed of a piezoelectric single crystal containing lead titanate and configured to detect an acoustic signal which is generated due to the energy of the irradiation light absorbed by a specific substance present in or on a subject.
    Type: Application
    Filed: October 28, 2003
    Publication date: January 18, 2007
    Inventors: Shoichi Kanayama, Kazuhiro Itsumi, Omar Khalil, Stanislaw Kantor
  • Patent number: 7043287
    Abstract: Devices and methods for non-invasively measuring at least one parameter of a sample, such as the presence of a disease condition, progression of a disease state, presence of an analyte, or concentration of an analyte, in a biological sample, such as, for example, a body part. In these devices and methods, temperature is controlled and is varied between preset boundaries. The methods and devices measure light that is reflected, scattered, absorbed, or emitted by the sample from an average sampling depth, dav, that is confined within a region in the sample wherein temperature is controlled. According to the method of this invention, the sampling depth dav, in human tissue is modified by changing the temperature of the tissue. The sampling depth increases as the temperature is lowered below the body core temperature and decreases when the temperature is raised within or above the body core temperature. Changing the temperature at the measurement site changes the light penetration depth in tissue and hence dav.
    Type: Grant
    Filed: October 15, 1999
    Date of Patent: May 9, 2006
    Assignee: Abbott Laboratories
    Inventors: Omar S. Khalil, Shu-Jen Yeh, Xiaomao Wu, Stanislaw Kantor, Charles F. Hanna, Tzyy-Wen Jeng
  • Patent number: 6662031
    Abstract: A method for the determination of hemoglobin and hematocrit by means of an apparatus that is capable of controlling the temperature of a defined subcutaneous volume of human skin. The method involves a calculation of hemoglobin concentration and hematocrit value that takes into consideration the values of optical parameters of the sample at various pre-set temperatures. The apparatus and method employ steady state optical measurements of samples, such as, for example, human tissue, by means of a reflectance tissue photometer and localized control of the temperature of the sample. According to the method of this invention, an optical signal from a defined subcutaneous volume of human skin is measured as the temperature of this volume is controlled. The method and apparatus of this invention allow determination of hemoglobin concentration and hematocrit value non-invasively in a population of subjects having different skin colors by means of steady state reflectance measurements.
    Type: Grant
    Filed: May 8, 2000
    Date of Patent: December 9, 2003
    Assignee: Abbott Laboratoies
    Inventors: Omar S. Khalil, Xiaomao Wu, Shu-jen Yeh, Charles F. Hanna, Stanislaw Kantor, Tzyy-Wen Jeng
  • Publication number: 20030212316
    Abstract: A method of monitoring a patient that comprises a non-invasive measurement of the hematocrit value or the concentration of hemoglobin coupled with the measurement of one or more vital signs. These vital signs include, but are not limited to, cardiac pulse rate, blood pressure, and arterial blood oxygenation. The invention also provides an apparatus for monitoring changes in the hematocrit value of a patient, in combination with one or more of the patient's vital signs.
    Type: Application
    Filed: May 10, 2002
    Publication date: November 13, 2003
    Inventors: Jeffrey M. Leiden, Omar S. Khalil, Eric Brian Shain, Stanislaw Kantor, Shu-jen Yeh, James J. Koziarz, Charles F. Hanna, Xiaomao Wu, Ronald R. Hohs
  • Patent number: 6615061
    Abstract: A method and apparatus for the measurement of trans-cutaneous diffuse reflectance at a single sampling distance for determining the concentration of an analyte in a biological sample, such as, for example, human tissue. The determination of the concentration of the analyte has been found to depend on the sampling distance and reaches an optimal result at a defined sampling distance for a given analyte and a given sample. The method involves measuring the light re-emitted from the sample at a distance from a light introduction site and correlating the intensity of the re-emitted light to the concentration of an analyte. For a given sample, the distance between the light collection site and a light introduction site (i.e., the sampling distance) corresponds to the depth from the surface into the sample at which scattering and absorption events significantly affect the intensity of re-emitted light (i.e., the sampling depth).
    Type: Grant
    Filed: August 3, 1999
    Date of Patent: September 2, 2003
    Assignee: Abbott Laboratories
    Inventors: Omar S. Khalil, Xiaomao Wu, Shu-jen Yeh, Charles F. Hanna, Stanislaw Kantor, Tzyy-Wen Jeng
  • Patent number: 6526298
    Abstract: A method for the determination of concentrations of analytes, e.g., glucose, and other metabolites in human tissue, wherein the temperature of a defined cutaneous volume of tissue, e.g., human skin, is controlled. The method involves calculating the concentration of an analyte in the tissue by taking into consideration the values of optical parameters of a sample of tissue measured in the defined cutaneous volume of the tissue at various temperatures. The selection of the defined volume is a function of the sampling distance along the surface of the tissue, the wavelength of light used to illuminate the tissue, and the temperature in the defined volume of tissue, which is a function of the temperature at the surface of the tissue. In one embodiment of the method of this invention, an optical signal re-emitted from a defined cutaneous volume of the tissue is measured, as the temperature of this volume is maintained at a constant value.
    Type: Grant
    Filed: October 20, 2000
    Date of Patent: February 25, 2003
    Assignee: Abbott Laboratories
    Inventors: Omar S. Khalil, Shu-jen Yeh, Charles F. Hanna, Stanislaw Kantor
  • Publication number: 20030023151
    Abstract: A method for collecting optical data at two morphologically similar, substantially non-overlapping, and preferably adjacent, areas on the surface of a tissue, while the temperature in each area is being maintained or modulated according to a temperature program. The optical data obtained are inserted into a mathematical relationship, e.g., an algorithm, that can be used to predict a disease state (such as the diabetes mellitus disease state) or the concentration of an analyte for indicating a physical condition (such as blood glucose level). This invention can be used to differentiate between to disease status, such as, for example, diabetic and non-diabetic. The method involves the generation of a calibration (or training) set that utilizes the relationship between optical signals emanating from the skin under different thermal stimuli and disease status, e.g., diabetic status, established clinically. This calibration set can be used to predict the disease state of other subjects.
    Type: Application
    Filed: April 13, 2001
    Publication date: January 30, 2003
    Inventors: Omar S. Khalil, Shu-jen Yeh, Stanislaw Kantor, Charles F. Hanna, Eric B. Shain